Neuro-oncological ventral antigen 1 (NOVA1): Implications in neurological diseases and cancers

32Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Neuro-oncological ventral antigen 1 (NOVA1) is a RNA-binding protein that interacts with RNA containing repeats of the YCAY sequence. This protein is a brain-specific splicing factor regulating neuronal alternative splicing. It has been increasingly recognized as an important contributor to neurological disorders and carcinogenesis. In this review, we summarize the biological functions and pathological roles of NOVA1. The clinical implications of NOVA1 will also be discussed.

Cite

CITATION STYLE

APA

Xin, Y., Li, Z., Zheng, H., Ho, J., Chan, M. T. V., & Wu, W. K. K. (2017, August 1). Neuro-oncological ventral antigen 1 (NOVA1): Implications in neurological diseases and cancers. Cell Proliferation. Blackwell Publishing Ltd. https://doi.org/10.1111/cpr.12348

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free